4.6 Article

Insulin attenuates apoptosis induced by high glucose via the PI3-kinase/Akt pathway in rat peritoneal mesothelial cells

Journal

NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 24, Issue 3, Pages 809-815

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfn598

Keywords

apoptosis; glucose; insulin; peritoneal dialysis; peritoneal mesothelial cell

Funding

  1. Peritoneal Function Research

Ask authors/readers for more resources

Background. Peritoneal mesothelial cells play an important role in peritoneal dialysis and are often exposed to dialysis fluid containing high glucose levels. Loss of peritoneal function is a major complication associated with long-term peritoneal dialysis. In this study, we hypothesized that high glucose levels induce apoptosis, and that insulin attenuates this apoptosis in peritoneal mesothelial cells. To clarify this hypothesis, we examined the effects of insulin on the phosphatidylinositol 3-kinase/Akt signaling pathway and apoptosis in rat peritoneal mesothelial cells. Methods. Phosphorylated insulin receptor and Akt were detected by western blot analysis. Apoptosis was evaluated by measuring caspase 3 activity and by TUNNEL staining. Results. Insulin (100 nmol/L) increased tyrosine phosphorylation of insulin receptor in peritoneal mesothelial cells. Furthermore, insulin (1-100 nmol/L) dose-dependently stimulated Akt phosphorylation. Treatment with the phosphatidylinositol 3-kinase inhibitors wortmannin (100 nmol/L) and LY294002 (10 mu mol/L) attenuated insulin-induced Akt phosphorylation, indicating that insulin phosphorylates Akt via a phosphatidylinositol 3-kinase-dependent pathway. Insulin attenuated caspase 3 activity and decreased the number of TUNNEL-positive cells. The phosphatidylinositol 3-kinase inhibitors and overexpression of a dominant-negative mutant of Akt inhibited the effect of insulin on apoptosis. Conclusions. The present data indicate that insulin attenuates high glucose-induced apoptosis via the phosphatidylinositol 3-kinase/Akt signaling pathway in peritoneal mesothelial cells. Therefore, the insulin signaling pathway may play a protective role in peritoneal function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Gastroenterology & Hepatology

Combination sandwich therapy using cyanoacrylate and polyglycolic acid sheets for refractory enterocutaneous fistula closure

Naoya Tada, Hideki Kobara, Noriko Nishiyama, Ken Ishimura, Kunihisa Uchita, Akira Nishiyama, Tsutomu Masaki

ENDOSCOPY (2021)

Review Peripheral Vascular Disease

Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker (MRB) in hypertension and chronic kidney disease

Ningning Wan, Asadur Rahman, Akira Nishiyama

Summary: Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker, has shown efficacy and good tolerability in treating hypertensive patients in Japan. In addition to lowering blood pressure, esaxerenone also demonstrates renoprotective effects. Clinical trials have indicated the potential clinical application of esaxerenone in treating renal diseases.

JOURNAL OF HUMAN HYPERTENSION (2021)

Article Surgery

Guidewire-assisted over-the-scope clip delivery method into the distal intestine: a case series

Naoya Tada, Hideki Kobara, Noriko Nishiyama, Shintaro Fujihara, Tadayuki Takata, Kazuhiro Kozuka, Takanori Matsui, Nobuya Kobayashi, Taiga Chiyo, Koji Fujita, Joji Tani, Tatsuo Yachida, Akihito Tsuji, Keiichi Okano, Yasuyuki Suzuki, Daisuke Nakano, Akira Nishiyama, Tsutomu Masaki

Summary: This study concludes that the guidewire-assisted OTSC delivery (GOD) method is a feasible and safe technique for delivering OTSC to the small and proximal large intestine.

MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES (2022)

Article Urology & Nephrology

Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation

Adriana Marton, Tatsuroh Kaneko, Jean-Paul Kovalik, Atsutaka Yasui, Akira Nishiyama, Kento Kitada, Jens Titze

Summary: SGLT2 inhibitors induce metabolic adaptations similar to aestivation, helping patients adapt to reduced energy availability and conserve water. These metabolic adjustments may contribute to the favorable cardiovascular and renal outcomes of SGLT2 inhibitor therapy.

NATURE REVIEWS NEPHROLOGY (2021)

Review Peripheral Vascular Disease

New Concept of Onco-Hypertension and Future Perspectives

Satoshi Kidoguchi, Naoki Sugano, Gorou Tokudome, Takashi Yokoo, Yuichiro Yano, Kiyohiko Hatake, Akira Nishiyama

Summary: Due to aging populations, the prevalence of hypertension, cardiovascular events, and cancer is increasing globally. Small-molecule inhibitors used in cancer therapy have a positive impact on prognosis and survival of cancer patients, leading to a rapid increase in cancer survivors with hypertension. However, there is a lack of evidence on optimal blood pressure control for cancer patients with hypertension, highlighting the need for further research on the concept of onco-hypertension.

HYPERTENSION (2021)

Article Surgery

Wafer paper and ring-mounted polyglycolic acid sheet method for shielding artificial gastric floor

Nobuya Kobayashi, Hideki Kobara, Noriko Nishiyama, Shintaro Fujihara, Kazuhiro Kozuka, Naoya Tada, Takanori Matsui, Taiga Chiyo, Tadayuki Takata, Koji Fujita, Joji Tani, Tatsuo Yachida, Keiichi Okano, Daisuke Nakano, Akira Nishiyama, Hirohito Mori, Tsutomu Masaki

Summary: The study demonstrated that the WaRP method has a high technical success rate and safety in reducing post-ESD bleeding after gastric ESD, making it a simple and reliable approach.

MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES (2022)

Article Surgery

Long-term outcomes of over-the-scope clip for refractory gastrointestinal diseases

Yasuhiro Goda, Hideki Kobara, Nobuya Kobayashi, Noriko Nishiyama, Shintaro Fujihara, Naoya Tada, Kazuhiro Kozuka, Takanori Matsui, Taiga Chiyo, Tingting Shi, Koji Fujita, Joji Tani, Tatsuo Yachida, Masashi Takata, Keiichi Okano, Daisuke Nakano, Akira Nishiyama, Hirohito Mori, Tsutomu Masaki

Summary: This study examined the clinical outcomes and long-term characteristics of patients treated with Over-The-Scope Clip (OTSC). The results showed a 100% clinical success rate and a 2.9% complication rate during the observation period. OTSC remains effective in the long-term.

MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES (2022)

Article Physiology

Adaptive physiological water conservation explains hypertension and muscle catabolism in experimental chronic renal failure

Johannes Kovarik, Norihiko Morisawa, Johannes Wild, Adriana Marton, Kaoru Takase-Minegishi, Shintaro Minegishi, Steffen Daub, Jeff M. Sands, Janet D. Klein, James L. Bailey, Jean-Paul Kovalik, Manfred Rauh, Susanne Karbach, Karl F. Hilgers, Friedrich Luft, Akira Nishiyama, Daisuke Nakano, Kento Kitada, Jens Titze

Summary: Our study found that rats with 5/6 nephrectomy showed polyuria due to the inability of their kidneys to concentrate urine, but they were able to adapt physiologically by mobilizing nitrogen and energy from muscle, increasing norepinephrine and copeptin levels, and reducing skin blood flow to compensate for transepidermal water loss. This complex physiologic-metabolic adjustment across multiple organs allowed the rats to stabilize their body water content despite persisting renal water loss, although it led to hypertension and muscle catabolism.

ACTA PHYSIOLOGICA (2021)

Article Surgery

The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study

Yohei Doi, Makoto Tsujita, Takayuki Hamano, Yoshitsugu Obi, Tomoko Namba-Hamano, Toshihide Tomosugi, Kenta Futamura, Manabu Okada, Takahisa Hiramitsu, Norihiko Goto, Akira Nishiyama, Asami Takeda, Shunji Narumi, Yoshihiko Watarai, Yoshitaka Isaka

Summary: Cholecalciferol supplementation did not significantly improve allograft outcomes in kidney transplant recipients, with no significant impact on eGFR change compared to placebo. However, it showed detrimental effects in patients with eGFR <45 mL/min/1.73 m(2).

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Hematology

Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function

Eri Muso, Soichi Sakai, Youske Ogura, Susumu Yukawa, Yoshiki Nishizawa, Noriaki Yorioka, Takao Saito, Masatoshi Mune, Satoshi Sugiyama, Yasuhiko Iino, Tsutomu Hirano, Motoshi Hattori, Tsuyoshi Watanabe, Hitoshi Yokoyama, Hiroshi Sato, Shunya Uchida, Takashi Wada, Tetsuo Shoji, Hiroaki Oda, Kiyoshi Mori, Hideki Kimura, Osamu Ito, Akira Nishiyama, Shoichi Maruyama, Reiko Inagi, Shoichi Fujimoto, Tatsuo Tsukamoto, Yusuke Suzuki, Hirokazu Honda, Tetsuya Babazono, Kazuhiko Tsuruya, Yukio Yuzawa

Summary: Many reports have demonstrated the therapeutic efficacy of LDL-Apheresis in improving heavy proteinuria and severely impaired renal function in cases of drug-resistant nephrotic syndrome. A post hoc analysis of the POLARIS study showed significant improvements in proteinuria and renal function in cases with normal and moderately impaired renal function, and a trend for improvement in severely impaired renal function. Most cases did not progress to end-stage renal disease within 2 years after LDL-A treatment.

THERAPEUTIC APHERESIS AND DIALYSIS (2022)

Article Health Care Sciences & Services

Changes in Prevalence and Health Checkup Coverage Rate of Chronic Kidney Disease (CKD) after Introduction of Prefecture-Wide CKD Initiative: Results of the Kagawa Association of CKD Initiatives

Tadashi Sofue, Taiga Hara, Yoko Nishijima, Satoshi Nishioka, Hiroyuki Watatani, Masahito Yamanaka, Norihiro Takahashi, Akira Nishiyama, Tetsuo Minamino

Summary: After the implementation of the NHI special health checkup and chronic kidney disease (CKD) initiative in Kagawa prefecture, there was an increase in the prevalence of CKD and the coverage rate of NHI health checkups.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Biochemistry & Molecular Biology

Association of Antihypertensive Effects of Esaxerenone with the Internal Sodium Balance in Dahl Salt-Sensitive Hypertensive Rats

Mai Hattori, Asadur Rahman, Satoshi Kidoguchi, Nourin Jahan, Yoshihide Fujisawa, Norihiko Morisawa, Hiroyuki Ohsaki, Hideki Kobara, Tsutomu Masaki, Akram Hossain, Akumwami Steeve, Akira Nishiyama

Summary: This study investigated the effects of the nonsteroidal mineralocorticoid receptor blocker esaxerenone on blood pressure and renal health in salt-loaded conditions. The results showed that esaxerenone significantly reduced blood pressure and attenuated renal damage induced by high salt intake. These effects were associated with the modulation of sodium homeostasis by esaxerenone.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Glucose Increases Hepatic Mitochondrial Antioxidant Enzyme Activities in Insulin Resistant Rats Following Chronic Angiotensin Receptor Blockade

Jose A. Godoy-Lugo, Max A. Thorwald, Dora A. Mendez, Ruben Rodriguez, Daisuke Nakano, Akira Nishiyama, Rudy M. Ortiz

Summary: This study found that long-term AT1 blockade can increase nuclear Nrf2 content and reduce the expression of antioxidant enzymes, thereby promoting the development of NAFLD. The angiotensin receptor blocker can alleviate the impact of hyperglycemia on Nrf2, suggesting its role in antioxidant defense.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

Potential Impact of Non-Steroidal Mineralocorticoid Receptor Antagonists in Cardiovascular Disease

Asadur Rahman, Nourin Jahan, Md Tanvir Rahman, Akira Nishiyama

Summary: Inappropriate mineralocorticoid receptor (MR) activation in cardiovascular cells has negative effects on cardiac remodeling and function. MR inhibition is an important strategy to overcome cardiovascular dysfunction, but the clinical application of steroidal MR antagonists is limited due to adverse effects. Newer non-steroidal MR antagonists show promise for clinical use, particularly in patients with type 2 diabetes and chronic kidney disease. Pre-clinical and clinical evidence supports the use of non-steroidal MR antagonists in treating cardiovascular disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Biochemistry & Molecular Biology

The Renin-Angiotensin-Aldosterone System in Metabolic Diseases and Other Pathologies

Rudy M. Ortiz, Ryousuke Satou, Jia L. Zhuo, Akira Nishiyama

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

No Data Available